CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:L/AC:L/Au:N/C:P/I:P/A:N
CVSS3
Attack Vector
PHYSICAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
NONE
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
AI Score
Confidence
High
EPSS
Percentile
12.6%
Successful exploitation of this vulnerability could allow an attacker to access, modify, or delete sensitive information. This includes electronic protected health information (ePHI), protected health information (PHI), and personally identifiable information (PII).
The following versions of BD Synapsys, a microbiology informatics software platform, are affected:
The affected product is vulnerable due to an insufficient session expiration. An unauthorized physical breach of a BD Synapsys workstation would be negligible due to the sequence of events that must occur in a specific order, however successful exploitation could lead to modification of ePHI, PHI, or PII. The result could cause delayed or incorrect treatment.
CVE-2022-30277 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N).
BD voluntarily reported this vulnerability through the CISA coordinated vulnerability disclosure program.
BD Synapsys v4.20 SR2 will be released in June 2022 and will remediate this vulnerability. Users receiving BD Synapsys v4.30 will be allowed to upgrade to v5.10, which is expected to be available by August 2022.
Additionally, BD recommends the following compensating controls for users working with the impacted versions of BD Synapsys:
For more information on this issue, please see the associated BD product security bulletin on the BD website.
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on cisa.gov/ics in the Technical Information Paper, ICS-TIP-12-146-01BβTargeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
CISA also recommends users take the following measures to protect themselves from social engineering attacks:
This vulnerability is not exploitable remotely. No known public exploits specifically target this vulnerability.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2022-30277
cisa.gov/ics
cisa.gov/ics
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-151-02
cwe.mitre.org/data/definitions/613.html
cybersecurity.bd.com/bulletins-and-patches/bd-synapsys-insufficient-session-expiration
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=BD%20Synapsys+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-151-02
www.cisa.gov/uscert/ics/recommended-practices
www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B
www.cisa.gov/uscert/sites/default/files/publications/emailscams_0905.pdf
www.cisa.gov/uscert/sites/default/files/publications/emailscams_0905.pdf
www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-151-02&title=BD%20Synapsys
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-151-02
www.oig.dhs.gov/
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=BD%20Synapsys&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-22-151-02
CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:L/AC:L/Au:N/C:P/I:P/A:N
CVSS3
Attack Vector
PHYSICAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
NONE
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
AI Score
Confidence
High
EPSS
Percentile
12.6%